Arteris, Inc. (NASDAQ:AIP – Get Free Report) major shareholder Bayview Legacy, Llc sold 26,106 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $31.97, for a total transaction of $834,608.82. Following the completion of the transaction, the insider owned 8,329,071 shares in the company, valued at approximately $266,280,399.87. The trade was a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Bayview Legacy, Llc also recently made the following trade(s):
- On Monday, August 3rd, Bayview Legacy, Llc sold 73,894 shares of Arteris stock. The shares were sold at an average price of $30.00, for a total transaction of $2,216,820.00.
- On Monday, July 6th, Bayview Legacy, Llc sold 125,976 shares of Arteris stock. The stock was sold at an average price of $35.79, for a total transaction of $4,508,681.04.
- On Thursday, July 2nd, Bayview Legacy, Llc sold 192,686 shares of Arteris stock. The shares were sold at an average price of $36.32, for a total value of $6,998,355.52.
- On Monday, June 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The shares were sold at an average price of $34.91, for a total value of $2,443,700.00.
- On Friday, May 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The stock was sold at an average price of $31.20, for a total value of $2,184,000.00.
Arteris Trading Up 2.2%
Shares of NASDAQ AIP opened at $31.62 on Friday. Arteris, Inc. has a 12-month low of $8.42 and a 12-month high of $50.26. The company has a market cap of $1.46 billion, a price-to-earnings ratio of -40.03 and a beta of 1.96. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.17. The stock’s 50 day simple moving average is $36.06 and its 200 day simple moving average is $26.16.
Hedge Funds Weigh In On Arteris
A number of institutional investors and hedge funds have recently bought and sold shares of AIP. Bank of New York Mellon Corp acquired a new position in Arteris during the 2nd quarter valued at about $4,779,000. State of Wyoming acquired a new stake in shares of Arteris in the 2nd quarter worth approximately $165,000. Walleye Trading LLC bought a new position in shares of Arteris in the second quarter valued at approximately $1,347,000. Versant Capital Management Inc boosted its holdings in shares of Arteris by 33.7% in the second quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock valued at $56,000 after acquiring an additional 290 shares in the last quarter. Finally, Janus Henderson Group PLC increased its stake in shares of Arteris by 10.4% during the first quarter. Janus Henderson Group PLC now owns 106,921 shares of the company’s stock valued at $1,758,000 after acquiring an additional 10,062 shares during the period. Institutional investors own 64.36% of the company’s stock.
Analysts Set New Price Targets
AIP has been the topic of a number of analyst reports. Roth Capital began coverage on shares of Arteris in a report on Tuesday. They issued a “buy” rating and a $40.00 price objective on the stock. Weiss Ratings cut shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. TD Cowen raised their price target on shares of Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Northland Securities set a $38.00 price target on Arteris in a report on Wednesday, May 13th. Finally, Jefferies Financial Group boosted their price objective on Arteris from $16.00 to $35.00 and gave the stock a “hold” rating in a research report on Wednesday, May 13th. Four investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Arteris has an average rating of “Moderate Buy” and a consensus price target of $38.50.
View Our Latest Stock Report on Arteris
Arteris News Roundup
Here are the key news stories impacting Arteris this week:
- Positive Sentiment: Arteris reported second-quarter revenue of $24.13 million, above the $23.48 million analyst consensus. More importantly, the company forecast third-quarter revenue of $24.0 million to $25.0 million and full-year 2026 revenue of $95.0 million to $98.0 million, both ahead of consensus estimates of $23.5 million and $94.2 million, respectively. The outlook suggests continued demand for Arteris’ semiconductor interconnect and system IP products. Arteris financial results and guidance
- Positive Sentiment: Roth Capital initiated coverage with a Buy rating and a $40 price target, while other analysts also maintain bullish targets. The new coverage adds support to the investment case and implies meaningful upside from recent trading levels. Roth Capital coverage
- Neutral Sentiment: Arteris appointed Saurabh Sinha as chief financial officer. The leadership change may improve investor focus on financial execution, although the announcement itself provides limited information about near-term earnings effects. Arteris CFO appointment
- Negative Sentiment: Second-quarter adjusted EPS was a loss of $0.10, missing the expected loss of $0.04 by $0.06. The larger-than-expected loss highlights ongoing profitability pressure despite the revenue beat. Arteris quarterly earnings
- Negative Sentiment: Several insiders reported sales, including CEO K. Charles Janac, Director Saiyed Atiq Raza, major shareholder Bayview Legacy, and Vice President Paul Alpern. While the sales represent relatively small portions of their remaining holdings in some cases, the concentration of insider selling could weigh on sentiment. Arteris insider selling
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Read More
- Five stocks we like better than Arteris
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
